MACARTNEY LAWSON
SEC CIK 1606831 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Dir | 51.1K | — | $1.29M | 9 | 2023-04-17 | 2026-01-02 |
Most active insiders at VKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lian Brian | Pres, CEO, Dir | — | $14.01M |
| 2 | ZANTE GREG | CFO | — | $2.82M |
| 3 | Mancini Marianna | COO | — | $2.73M |
| 4 | Rowland Charles A Jr | Dir | — | $2.13M |
| 5 | FOEHR MATTHEW W | Dir | — | $561.8K |
| 6 | Aubuchon Neil William | Chief Commercial Off | $149.9K | — |
| 7 | Kelly-Gemmell Dorothy Elizabeth | Dir | — | — |
| 8 | Rouan Sarah Kathryn | Dir | — | — |
| 9 | MACARTNEY LAWSON | Dir | — | — |
| 10 | SINGLETON J MATTHEW | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | A - Grant | $0.00 | +3,150 | 51.1K | +7% | $0 |
| D | 2024-11-08 | 2024-11-08 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | M - OptEx | $5.80 | +2,000 | 50.0K | +4% | +$11.6K |
| D | 2024-11-08 | 2024-11-08 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | S - Sale+OE | $68.67 | -2,000 | 48.0K | -4% | -$137.3K |
| D | 2023-05-18 | 2023-05-16 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | S - Sale+OE | $24.00 | -16.0K | 48.0K | -25% | -$384.0K |
| D | 2023-05-18 | 2023-05-16 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | M - OptEx | $1.19 | +16.0K | 64.0K | +33% | +$19.0K |
| D | 2023-04-24 | 2023-04-24 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | M - OptEx | $3.33 | +16.0K | 64.0K | +33% | +$53.3K |
| D | 2023-04-24 | 2023-04-24 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | S - Sale+OE | $22.00 | -16.0K | 48.0K | -25% | -$352.0K |
| D | 2023-04-18 | 2023-04-17 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | M - OptEx | $8.00 | +20.8K | 68.8K | +43% | +$166.3K |
| D | 2023-04-18 | 2023-04-17 | VKTX | Viking Therapeutics, Inc. | MACARTNEY LAWSON | Dir | S - Sale+OE | $20.00 | -20.8K | 48.0K | -30% | -$415.7K |
Purchase Sale Sale after option exercise All abbreviations